Occludin 抗体 (AA 282-415)
Quick Overview for Occludin 抗体 (AA 282-415) (ABIN7477543)
抗原
See all Occludin (OCLN) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 282-415
-
免疫原
- ecombinant fragment of human Occludin protein (around aa 282-415) (exact sequence is proprietary)
-
亚型
- IgG
-
-
-
-
应用备注
- IHC 1:100-1:200
-
说明
-
Positive Control: Colon: A strong membranous occludin staining of epithelial cells should be seen with a particularly strong staining at the apical/luminal membranes.
Negative Control: Colon: All non-epithelial and non-endothelial cells must not show any occludin staining.
-
实验流程
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- Occludin (OCLN)
-
别名
- Occludin
-
背景
- BLCPMG, Occludin, OCLN, Phosphatase 1 regulatory subunit 115, PPP1R115, PTORCH1, Tight junction protein occludin,Occludin antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- Q16625
-
途径
- Cell-Cell Junction Organization, Hepatitis C
抗原
-